President Trump’s recent appointment of Kyle Diamantas as acting FDA commissioner following Marty Makary’s resignation has positioned the FDA deputy commissioner for food as the clear frontrunner in trader assessments for the permanent role. Diamantas assumed acting duties in mid-May 2026 after serving in senior FDA food-policy positions and has received public White House support for advancing administration priorities on food safety and regulatory reform. Other names under active consideration, including former commissioner Stephen Hahn and former acting commissioner Brett Giroir, register lower probabilities consistent with their more limited recent involvement in day-to-day agency operations. The market also prices a meaningful chance of no formal announcement before year-end, reflecting the ongoing search process and typical timelines for Senate-confirmed appointments.